MOTS-C

Research-grade MOTS-C represents a benchmark in mitochondrial peptide synthesis. Each batch is produced using SPPS and purified via preparative HPLC. Final identity and molecular weight are confirmed through ESI-MS. Independent laboratories handling sensitive peptide-binding assays depend on this level of synthesis precision, particularly when comparing MOTS-C against other mitochondrial-derived peptides such as Humanin or SS-31.

MOTS-C research centers on its proposed role as a mitochondrial-to-nuclear signaling molecule, with investigators examining how it interfaces with AMPK activation and downstream metabolic transcription factors. Current literature points to its relevance in cellular energy homeostasis, exercise physiology, and adaptive stress response models. Its comparatively rapid binding kinetics make it a useful candidate for dose-response titration studies and comparative pharmacological profiling.

Every batch of MOTS-C is synthesized using Solid-Phase Peptide Synthesis (SPPS) and purified via preparative HPLC to eliminate truncated sequences and synthesis byproducts. Final identity confirmation is performed via Electrospray Ionization Mass Spectrometry (ESI-MS), verifying exact molecular weight. Each lot ships with a Certificate of Analysis documenting purity exceeding 99%, giving researchers traceable, batch-specific verification before use in any laboratory protocol.

This product is strictly for research and laboratory use only. It is not approved by the FDA or any global regulatory body for human consumption, veterinary use, or therapeutic application. The purchaser assumes all responsibility for the proper handling, storage, and application of this compound. It must only be handled by qualified professionals in a controlled laboratory setting. By purchasing this product, you agree to abide by all local and international laws regarding the use of research chemicals.